Influenza and Other Respiratory Viruses
© 2013 John Wiley & Sons Ltd
All articles submitted from 1st October 2013 are published under the terms of the Creative Commons Attribution License. Articles submitted before this date were published under the agreement as stated in the final article.
Edited By: Jonathan Van Tam
Impact Factor: 1.471
ISI Journal Citation Reports © Ranking: 2012: 29/34 (Virology); 59/70 (Infectious Diseases)
Online ISSN: 1750-2659
All manuscripts should be submitted via ScholarOne Manuscripts at http://mc.manuscriptcentral.com/irv. Please contact Delia Malim-Robinson at the Influenza and Other Respiratory Viruses Editorial Office if you have any queries concerning the submission of your paper.
Manuscripts should have: a wide margin, double spacing, and numbered pages beginning with the title page. The title of the paper, name and address of each author, and the name of the institution where the work has been carried out should appear on the title page, as should the name and full postal address (with phone/fax numbers and e-mail) of the corresponding author only. The corresponding author is responsible for reading the proofs and communicating with the other authors, and informing the Influenza and Other Respiratory Viruses Editorial Office of any change in details until the paper is published.
Wiley-Blackwell reserves the right to contact another author if the corresponding author is not available to check proofs. Authors may use UK or American English and syntax but consistency must be maintained within the paper. The Editor reserves the right to make corrections, both literary and technical, to the papers.
Open Access Agreement
If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.
The following license agreement is available:
Creative Commons Attribution License OAA
To preview the terms and conditions of this open access agreement, please visit
Article Publication Charges
Influenza and Other Respiratory Viruses is an open access journal, and you or your funder will be required to pay an article publication charge on acceptance. For more details on charges and available discounts, please see here.
PubMed Central (PMC)
PubMed Central (PMC) is created by the U.S. National Institutes of Health (NIH) and is a digital archive of biomedical and life sciences journal literature. It is a full text database, which gives readers free access to the full text version of articles. Wiley Open Access journals will deposit all articles into PMC upon publication of an online issue, on a monthly basis. The final published versions of the articles are sent to PMC.
Disclosure and competing interest statement
Authors are required to disclose financial interests in any company or institution that might benefit from their publication. A competing interest exists when a primary interest (such as patients’ welfare or the validity of research) might be influenced by a secondary interest (such as financial gain or personal rivalry). It may arise for the authors of an Influenza and Other Respiratory Viruses article when they have a financial interest that may influence their interpretation of their results or those of others. Financial interests are the easiest to define and they have the greatest potential to influence the objectivity, integrity or perceived value of a publication. They may include any or all, but are not limited to, the following:
• Personal financial interests: Stocks or shares in companies that may gain or lose financially through publication; consultant fees or fees from speakers bureaus other forms of remuneration from organisations that may gain or lose financially; patents or patent applications whose value may be affected by publication.
• Funding: Research support from organisations that might gain or lose financially through publication of the paper.
• Employment: Recent, present or anticipated employment of you or a family member by any organization that may gain or lose financially through publication of the paper.
• Patent rights
• Consultancy work.
All authors must disclose competing interests, or state “none” via the Journal's ScholarOne Manuscripts website.
All sources of funding must be disclosed in the Acknowledgments section of the paper. List governmental, industrial, charitable, philanthropic and/or personal sources of funding used for the studies described in the manuscript. Attribution of these funding sources is preferred.
• This work was supported by a grant from the National Institutes of Health, USA (DKxxxx to AB).
• This work was supported by the Crohn's and Colitis Foundation of Canada (grant to AB and CD).
• This work was supported by a grant from Big Pharma Inc. (to AB) and equipment was donated by Small Pharma Inc. EF received a graduate studentship award from the University of xxxxx.
The aim of the statement is not to eradicate competing interests, as they are almost inevitable. Papers will not be rejected because there is a competing interest, but a declaration on whether or not there are competing interests will be added to the paper. For papers where there are no competing interests, all authors must include the statement ‘Competing interests: the authors have no competing interests.’
Influenza and Other Respiratory Viruses employs a plagiarism detection system. By submitting your manuscript to this journal you accept that your manuscript may be screened for plagiarism against previously published works.
What to submit
It is recommended that text files are submitted in Word format, ﬁgures in TIFF or EPS, although worksheets in Excel, Powerpoint ﬁgures can be used. RRF and PDF originals are not recommended due to potential conversion errors in the system. Please note that if the program extension is not present in the ﬁlename, it must be added by the author before uploading the ﬁle: e.g. ﬁlename: Antithrombin should be renamed Antithrombin.doc; Figure1 should be renamed Figure1.eps or Figure1.tiff, etc. Without the extension, the ﬁles cannot be recognized by the system and therefore may not convert properly: this will cause delays in reviewing the material. Authors must state either on the cover page of the manuscript (under the title and afﬁliation), or in the covering letter to the editor, the word count of the abstract (which must not exceed 250 words) and the word count of the text (not exceeding 5000 words) separately.
NEW: Pre-submission English-language editing
Authors for whom English is a second language may choose to have their manuscript professionally edited before submission to improve the English. A list of independent suppliers of editing services can be found at http://authorservices.wiley.com/bauthor/english_language.asp. All services are paid for and arranged by the author, and use of one of these services does not guarantee acceptance or preference for publication.
Types of Articles
Review articles, which must undergo peer review, will generally be solicited, but unsolicited reviews on timely subjects will be considered. Review articles should be 4,000 words or less with selected references, and no more than three authors.
Should not exceed 5,000 words (including tables, ﬁgures, and references). Contributors who do not meet the criteria for authorship can be listed in ‘Acknowledgements’.
Letters to the Editors
Should not normally exceed three typewritten pages and include not more than one table or ﬁgure, nor more than five authors.
Short reports may include up to 1500 words of text and up to 15 references. A summary of up to 100 words should be followed by continuous text, subdivided if appropriate. Publication of initial results which will lead to more substantial papers will generally be discouraged.
In addition to the full title, authors should provide a short version (running head), not more than 50 characters long, including spaces.
Authorship implies a substantial contribution to concept and design, analysis and/or interpretation of data; critical writing or revising the intellectual content; and ﬁnal approval of the version to be published. A maximum of eight authors can be listed under the title for an original article. Should it be necessary to list more names, the editors require that an Addendum be included in the manuscript where the role of each author in the study is speciﬁed. The Addendum should be placed at the end of the Discussion or Conclusion section, before the Acknowledgements. Give names as full first names followed by surnames, which should be clearly linked to the respective addresses, if more than one, by use of alphabets in superscript. Contributors who do not meet the criteria for authorship and their respective contributions should be listed, with their permission, in ‘Acknowledgements’ or an appendix. Technical assistance should be acknowledged in a separate paragraph.
Original articles should have a structured abstract of 250 words or less including the following headings: Background, Objectives, Patients/Methods, Results and Conclusions.
Provide no more than six keywords in alphabetical order following the Summary.
Give generic names of drugs. Full names of substances with abbreviations must be given at ﬁrst mention; thereafter, use the abbreviation. Symbols should be inserted as per the instructions on the submission site.
Only three levels of headings are used in Influenza and Other Respiratory Viruses (the third being a run-on heading, where the text follows on the same line). Work must be rewritten if any part of it contains more than three types of heading in succession.
Only papers closely related to the author’s work should be referenced; exhaustive lists should be avoided. Verify all references for completeness and accuracy, and format references as a plain, unstructured list. References are Vancouver style, with numbers in superscript in the text and a numbered list, with up to six authors included in each reference, at the end. For references with more than six authors, the first three should be listed, followed by et al. References to personal communications, unpublished data, and manuscripts either ‘in preparation’ or ‘submitted for publication’ should be inserted, if essential, in the text only and not listed in the references. They should include authors’ names, principal institution and city. Examples of correct forms of references are given below.
(1) Standard journal article. Ranasinghe E, Harrison JF: Bruising following blood donation, its management and the response and subsequent return rates of affected donors. Trans Med 2000; 10:113-116.
(2) Monograph. Mollison PL, Engelfriet CP, Contreras M: Blood Transfusion in Clinical Medicine, ed 10. Oxford, Blackwell Science, 1997.
(3) Corporate author. American Medical Association Department of Drugs. AMA drug evaluations. 3rd edn. Littleton: Publishing Sciences Group, 1977
(4) Edited book. Luzzatto L, Karadimitris A: The molecular basis of anaemia; in Provan D, Gribben J (ed): Molecular Haematology. Oxford, Blackwell Science, 2000.
(5) Published proceedings paper. DuPont B. Bone marrow transplantation in severe combined immunodeficiency with an untreated MLC compatible donor. In: White HJ, Smith R, eds. Proceedings of the Third Annual Meeting of the International Society for Experimental Haematology. Houston: International Society for Experimental Haematology, 1974:44-6.
Publications ‘in press’ should be updated as soon as possible. For further examples, see the ‘Uniform Requirements for Manuscripts Submitted to Biomedical Journals’ at http://www.icmje.org/index.html.
Tables. There should be as few tables as possible, containing only essential data. Verify information for accuracy and consistency with the manuscript’s text. Each table should be given an Arabic number. The title (legend) of the table should contain only minimal text. Any other information, such as deﬁnitions of abbreviations, probability statistics, etc., should be in the table footnote; if symbols are necessary, they should be the same as given for the authors’ details above. Headings and columns should be laid out clearly; avoid use of sub-headings. Avoid wordy, over-full tables. Any blank cells should have a dash.
A legend should be provided for each illustration. Photomicrographs should state the original magniﬁcation. Legends should provide sufficient information to allow the reader comprehension without reference to the text, and should be grouped at the end of the manuscript. Illustrations should be referred to in the text as ‘Figs’ and be given Arabic numbers. The ﬁnal width of the ﬁgures will be either 82, 114 or 173 mm. Lines should be of sufficient thickness to stand reduction (no less than 4 mm wide for a 50% reduction), and letters should be a minimum of 9 pt Arial or an equivalent size. For details of Wiley Blackwell’s electronic artwork standards, please go to http://authorservices.wiley.com/bauthor/illustration.asp.
If submitting ﬁnal artwork electronically, please read the information at http://authorservices.wiley.com/bauthor/illustration.asp . Vector graphics (e.g., line artwork) should be saved in Encapsulated Postscript Format (EPS) and bitmap ﬁles (e.g. photographs) should be saved in Tagged Image File Format (TIFF). Line art must be scanned at a minimum of 800 dpi; photographs at a minimum of 300 dpi.
The corresponding author will receive an email alert containing a link to a web site. A working e-mail address must therefore be provided for the corresponding author. The proof can be downloaded as a PDF (portable document format) file from this site. Acrobat Reader will be required in order to read this file. This software can be downloaded (free of charge) from the following web site: http://www.adobe.com/products/acrobat/readstep2.html
This will enable the file to be opened, read on screen and printed out in order for any corrections to be added. Further instructions will be sent with the proof.
Author Services enables authors to track their article – once it has been accepted – through the production process to publication online. Authors can check the status of their articles online and choose to receive automated e-mails at key stages of production. The author will receive an e-mail with a unique link that enables them to register and have their article automatically added to the system. Please ensure that a complete e-mail address is provided when submitting the manuscript. Visit http://authorservices.wiley.com/bauthor/ for more details on online production tracking and for a wealth of resources including FAQs and tips on article preparation, submission and more.
Influenza and Other Respiratory Viruses is covered by Wiley Blackwell’s Early View service. Early View articles are complete full-text articles published online in advance of their publication in an online issue. Articles are therefore available as soon as they are ready, rather than having to wait for the next scheduled online issue. Early View articles are complete and final. They have been fully reviewed, revised and edited for publication, and the authors’ final corrections have been incorporated. Because they are in final form, no changes can be made after online publication. The nature of Early View articles means that they do not yet have volume, issue or page numbers, so Early View articles cannot be cited in the traditional way. They are therefore given a Digital Object Identifier (DOI), which allows the article to be cited and tracked before it is allocated to an issue. After online publication in an issue, the DOI remains valid and can continue to be used to cite and access the article.
Access to the final PDF offprint or your article will be available via Author Services. Please therefore sign up for Author Services if you would like to access your article PDF offprint and enjoy the many other benefits the service offers.
Author Material Archive Policy
Please note that unless speciﬁcally requested, Wiley Blackwell will dispose of all hardcopy or electronic material submitted two months after publication. If you require the return of any material submitted, please inform the Editorial Office or Production Editor as soon as possible.